GLP-1 Receptor Agonists Linked to Improved Survival in Type 2 Diabetes Patients with Brain Metastases
A groundbreaking cohort study recently published in JAMA Network Open has revealed a remarkable association between the use of glucagon-like peptide–1 receptor agonists (GLP-1 RAs)...
















